» Articles » PMID: 38510580

Cortical Microstructural Involvement in Cerebral Small Vessel Disease

Overview
Date 2024 Mar 21
PMID 38510580
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In cerebral small vessel disease (CSVD), cortical atrophy occurs at a later stage compared to microstructural abnormalities and therefore cannot be used for monitoring short-term disease progression. We aimed to investigate whether cortical diffusion tensor imaging (DTI) and quantitative (q) magnetic resonance imaging (MRI) are able to detect early microstructural involvement of the cerebral cortex in CSVD.

Materials And Methods: 33 CSVD patients without significant cortical or whole-brain atrophy and 16 healthy control subjects were included and underwent structural MRI, DTI and high-resolution qMRI with T, T* and T mapping at 3 T as well as comprehensive cognitive assessment. After tissue segmentation and reconstruction of the cortical boundaries with the Freesurfer software, DTI and qMRI parameters were saved as surface datasets and averaged across all vertices.

Results: Cortical diffusivity and quantitative T values were significantly increased in patients compared to controls ( < 0.05). T values correlated significantly positively with white matter hyperintensity (WMH) volume ( < 0.01). Both cortical diffusivity and T showed significant negative associations with axonal damage to the white matter fiber tracts ( < 0.05).

Conclusions: Cortical diffusivity and quantitative T mapping are suitable to detect microstructural involvement of the cerebral cortex in CSVD and represent promising imaging biomarkers for monitoring disease progression and effects of therapeutical interventions in clinical studies.

References
1.
Heinen R, Groeneveld O, Barkhof F, de Bresser J, Exalto L, Kuijf H . Small vessel disease lesion type and brain atrophy: The role of co-occurring amyloid. Alzheimers Dement (Amst). 2020; 12(1):e12060. PMC: 7364862. DOI: 10.1002/dad2.12060. View

2.
Mestre H, Kostrikov S, Mehta R, Nedergaard M . Perivascular spaces, glymphatic dysfunction, and small vessel disease. Clin Sci (Lond). 2017; 131(17):2257-2274. PMC: 5567781. DOI: 10.1042/CS20160381. View

3.
Song S, Sun S, Ju W, Lin S, Cross A, Neufeld A . Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage. 2003; 20(3):1714-22. DOI: 10.1016/j.neuroimage.2003.07.005. View

4.
Morris J, Mohs R, Rogers H, Fillenbaum G, HEYMAN A . Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull. 1988; 24(4):641-52. View

5.
Smith S . Fast robust automated brain extraction. Hum Brain Mapp. 2002; 17(3):143-55. PMC: 6871816. DOI: 10.1002/hbm.10062. View